The results of this study showed that YKL-40 levels in both peripheral blood and CSF were higher in AD patients aged 60 to 69 than in HCs, but this was not a significant difference for those aged 70 to 79 in peripheral blood. This evidence concerns the gene CHI3L1 and Alzheimer disease.